Studies show divergent CHIT1 patterns in SMA patients: adult levels increase post-nusinersen (reflecting neuroinflammation without clinical correlation), while pediatric levels decrease during treatment (suggesting treatment response), with an inverse trend between CHIT1 and motor function in children. This evidence concerns the gene CHIT1 and proximal spinal muscular atrophy.